Maj J, Sowińska H, Baran L
Arch Immunol Ther Exp (Warsz). 1976;24(2):197-203.
In a previous study, anticataleptic action of cyproheptadine was reported. The present investigation deals with the influence of WA-335 (9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol), another antagonist of serotonin, on catalepsy induced in rats with spiroperidol, pimozide, fluphenazine and reserpine. WA-335 antagonized catalepsy induced by these neuroleptics (the effect on reserpine-induced catalepsy was weakest). Joint administration of WA-335 and L-DOPA with an inhibitor of peripheral decarboxylase, or WA-335 and amantadine produced a stronger antagonistic effect (spiroperidol catalepsy) than either of these substances separately. WA-335 did not prevent catalepsy induced with physostigmine.
在先前的一项研究中,曾报道过赛庚啶的抗僵住症作用。本研究探讨了另一种5-羟色胺拮抗剂WA - 335(9,10 - 二氢 - 10 -(1 - 甲基 - 4 - 哌啶叉)- 9 - 蒽醇)对用氟哌啶醇、匹莫齐特、氟奋乃静和利血平诱发大鼠僵住症的影响。WA - 335拮抗了这些抗精神病药物诱发的僵住症(对利血平诱发僵住症的作用最弱)。WA - 335与外周脱羧酶抑制剂联合使用左旋多巴,或WA - 335与金刚烷胺联合使用,产生的拮抗作用(氟哌啶醇僵住症)比单独使用这些物质中的任何一种都更强。WA - 335不能预防毒扁豆碱诱发的僵住症。